Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.8765 USD
−190.42 M USD
0.00 USD
51.78 M
About AlloVir, Inc.
Sector
Industry
CEO
Vikas Sinha
Website
Headquarters
Waltham
Founded
2013
FIGI
BBG00P80SH34
AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.
Rookie Opinion:I think this stock is poised to rip Higher. This is an Under the Radar Pharma company located in Waltham, Massachusetts. It has a PH3 Polyvalent vaccine. Gilead is in thsi company too
endpts.com
Gilead's virology lead and remdesivir developer Brainard jumps ship to run AlloVir
By Ben AdamsMar 23
May see a big selloff, beware! 💰These are just the sales for this year:
2022-03-11 19:14:59
2022-03-10
ALVR Hallal David Dir, 10% S - Sale $7.48 -65,725 17,427,929 0% -$491,850
2022-03-03 16:15:47
2022-03-02
ALVR Van Beek Jeroen B Chief Commercial Officer S - Sale $9.01 -516 382,384 0% -$4,651
2022-02-18 16:30:44
2022-02-
$ALVR Allovir Inc $60.00 Breakout target
Potential entry level above $49.00
target price $60.00 to Fibonacci Cluster.
indicators bullish.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALVR is 0.4742 USD — it has increased by 11.39% in the past 24 hours. Watch AlloVir, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange AlloVir, Inc. stocks are traded under the ticker ALVR.
ALVR stock hasn't changed in a week, the month change is a −22.41% fall, over the last year AlloVir, Inc. has showed a −37.73% decrease.
ALVR reached its all-time high on Dec 23, 2020 with the price of 48.9600 USD, and its all-time low was 0.4021 USD and was reached on Dec 16, 2024. View more price dynamics on ALVR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALVR stock is 13.26% volatile and has beta coefficient of −0.46. Track AlloVir, Inc. stock price on the chart and check out the list of the most volatile stocks — is AlloVir, Inc. there?
Today AlloVir, Inc. has the market capitalization of 52.01 M, it has decreased by −9.50% over the last week.
Yes, you can track AlloVir, Inc. financials in yearly and quarterly reports right on TradingView.
AlloVir, Inc. is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
ALVR net income for the last quarter is −4.13 M USD, while the quarter before that showed −6.08 M USD of net income which accounts for 32.09% change. Track more AlloVir, Inc. financial stats to get the full picture.
No, ALVR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 112.00 employees. See our rating of the largest employees — is AlloVir, Inc. on this list?
Like other stocks, ALVR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AlloVir, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AlloVir, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AlloVir, Inc. stock shows the sell signal. See more of AlloVir, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.